Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5059478 | 1.00 | SMPD1 (0.32) | SMPD1 | |
| SCHEMBL5059477 | 0.83 | BTN3A1 (0.40) | — | |
| SCHEMBL5064882 | 0.83 | BTN3A1 (0.40) | — | |
| SCHEMBL6724326 | 0.79 | — | — | |
| SCHEMBL1065866 | 0.79 | — | — | |
| SCHEMBL43278 | 0.75 | SMPD1 (0.34) | SMPD1 | |
| Phosphoric Acid SCHEMBL2148162 | 0.73 | SMPD1 (0.33) | SMPD1 | |
| SCHEMBL25032559 | 0.67 | PGK1 (0.44) | SMPD1 | |
| SCHEMBL8056927 | 0.66 | — | — | |
| SCHEMBL25274614 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080318227-A1 | Intermediates and enzymes of the non-mevalonate isoprenoid pathway | BACHER ADELBERT | 2008-12-25 | — | — | US | disclosed |
| US-7297509-B2 | Intermediates and enzymes of the non-mevalonate isoprenoid pathway | Bacher, Adelbert (DE) | 2007-11-20 | — | — | US | disclosed |
| US-20040176570-A1 | Intermediates and enzymes of the non-mevalonate isoprenoid pathway | ROHDICH, FELIX (DE) | 2004-09-09 | — | — | US | disclosed |
| EP-1377663-A2 | INTERMEDIATES AND ENZYMES OF THE NON-MEVALONATE ISOPRENOID PATHWAY | Bacher, Adelbert (DE) | 2004-01-07 | — | — | EP | disclosed |
| WO-2002083720-A2 | INTERMEDIATES AND ENZYMES OF THE NON-MEVALONATE ISOPRENOID PATHWAY | BACHER ADELBERT (DE) | 2002-10-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040176570-A1 | Intermediates and enzymes of the non-mevalonate isoprenoid pathway | FDPS, DHPS, COASY | SMPD1 851/4885 |
| US-20080318227-A1 | Intermediates and enzymes of the non-mevalonate isoprenoid pathway | FDPS, DHPS, COASY | SMPD1 823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.